These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20223956)

  • 21. [Components of monitoring drug resistance of tuberculosis agent in the evaluation of effectiveness of the national tuberculosis control program].
    Popov SA; Dorozhkova IR; Medvedeva IM
    Probl Tuberk; 2001; (2):18-20. PubMed ID: 11490457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.
    Matee M; Mfinanga S; Holm-Hansen C
    APMIS; 2009 Apr; 117(4):263-7. PubMed ID: 19338514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance evaluation program for Mycobacterium tuberculosis drug-susceptibility testing process.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jan; 43(1):17-8. PubMed ID: 8272047
    [No Abstract]   [Full Text] [Related]  

  • 24. [Resistance of Mycobacterium tuberculosis to antituberculotic drugs in Czech Republic in 2003].
    Homolka J; Krejbich F; Havelková M
    Cas Lek Cesk; 2004; 143(12):836-9. PubMed ID: 15730215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Resistance to antitubercular drugs in strains of Mycobacterium tuberculosis isolated in Spain].
    Ausina Ruiz V; Lonca Giménez J
    Rev Clin Esp; 1999 Mar; 199(3):121-5. PubMed ID: 10230288
    [No Abstract]   [Full Text] [Related]  

  • 26. [Impact of drug resistance on the fitness of Mycobacteruim tuberculosis of the genotype W-Beijing].
    Tungusova OS; Mar'iandyshev AO; Kaugant DA; Sandven P; Bjeune G
    Probl Tuberk Bolezn Legk; 2005; (8):46-50. PubMed ID: 16209021
    [No Abstract]   [Full Text] [Related]  

  • 27. Global health engagement with North Korea.
    Park JJ; Shin HY; Atun R
    BMJ; 2018 Jun; 361():k2547. PubMed ID: 29884659
    [No Abstract]   [Full Text] [Related]  

  • 28. [The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories].
    Mitarai S;
    Kekkaku; 2005 Apr; 80(4):349-58. PubMed ID: 15991600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs.
    Ann Pharmacother; 2006 May; 40(5):1007-8. PubMed ID: 16670365
    [No Abstract]   [Full Text] [Related]  

  • 30. Underestimated Burden: Non-Communicable Diseases in North Korea.
    Ha S; Lee YH
    Yonsei Med J; 2019 May; 60(5):481-483. PubMed ID: 31016911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for surveillance of drug resistance in tuberculosis. WHO Geneva/IUATLD Paris. International Union Against Tuberculosis and Lung Disease.
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):72-89. PubMed ID: 9562116
    [No Abstract]   [Full Text] [Related]  

  • 32. [Possibilities of advances in the determination of drug resistance of tubercle bacilli].
    Buraczewska M
    Gruzlica; 1971 Aug; 39(8):729-37. PubMed ID: 4999630
    [No Abstract]   [Full Text] [Related]  

  • 33. North Korea--who will help?
    Lancet; 2012 Jan; 379(9810):2. PubMed ID: 22225655
    [No Abstract]   [Full Text] [Related]  

  • 34. Has the time come to discontinue proficiency testing?
    Salfinger M; Ahmedov S
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1193. PubMed ID: 19793421
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug resistance in tuberculosis.
    Ebrahim GJ
    J Trop Pediatr; 2007 Jun; 53(3):147-9. PubMed ID: 17526511
    [No Abstract]   [Full Text] [Related]  

  • 36. [Drug resistance of Mycobacterium tuberculosis in patients with pulmonary tuberculosis treated in the santorium in Abastumani].
    Shilakadze EM; Margadze GKh; Zautashvili MG
    Probl Tuberk; 1975; (3):79. PubMed ID: 124432
    [No Abstract]   [Full Text] [Related]  

  • 37. [Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)].
    Tungusova OS; Mar'iandyshev AO
    Probl Tuberk; 2001; (6):48-9. PubMed ID: 11641963
    [No Abstract]   [Full Text] [Related]  

  • 38. [Surveillance of resistance of Mycobacterium tuberculosis to anti-TB drugs in Cuba, 1995-1998].
    Montoro E; Echemendía M; Lemus D; Marrero A; Llanes MJ; Valdivia JA
    Biomedica; 2004 Jun; 24 Supp 1():80-4. PubMed ID: 15495575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ecological restoration. Seeking cures for North Korea's environmental ills.
    Stone R
    Science; 2012 Mar; 335(6075):1425-6. PubMed ID: 22442451
    [No Abstract]   [Full Text] [Related]  

  • 40. Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada.
    Bozeman L; Burman W; Metchock B; Welch L; Weiner M;
    Clin Infect Dis; 2005 Feb; 40(3):386-91. PubMed ID: 15668861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.